Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,803 total articles
Preformed Line Products (PLPC) just hit a 52-week high but technical momentum and valuation look stretched. This trade idea lays out a mid-term short with a clear entry, stop, and target, plus catalysts and risks to monitor.
Microsoft's stock has sold off sharply into technical and sentiment support. Fundamentals remain intact: $2.95T market cap, 30% ROE, $77B of free cash flow and a modest debt load. With RSI near 32 and short-interest moderate, this is a tactical long for patient traders who want defined risk and a clear thesis for recovery over the next 45 trading d…
Kirby is set to benefit from a recovery in inland barge demand, resilient coastal volumes, and rising power-generation aftermarket work. With strong free cash flow ($405.7M), a conservative balance sheet (debt/equity 0.28) and an $8M share repurchase authorization on the books, the risk/reward favors a mid-term long trade: entry $129.17, target $15…
The Trade Desk (TTD) is trading near its 52-week low after a brutal multiple contraction. Fundamentals still show double-digit growth and strong free cash flow; technicals are oversold. This trade targets a mid-term rebound as ad buyers reallocate budgets and identity solutions stabilize.
The Hartford (HIG) delivered another quarter of disciplined underwriting and rising investment income, supporting shareholder returns and leaving valuation attractive at ~11x earnings. We upgrade HIG to a buy and recommend a mid-term swing trade: enter at $141.00, stop $132.00, target $156.00 (45 trading days).
Celsius rebuilt after a painful inventory cycle and a big acquisition, delivering strong free cash flow and revenue acceleration. The chart shows the stock digesting gains, giving a tactical swing opportunity. We lay out an entry at $47.73, a $60 target and a $42.00 stop, with a 45-trading-day time horizon and explicit risks tied to execution, comp…
Rheinmetall (RNMBY) is well positioned to capture outsized revenue and margin expansion as German and NATO defense budgets accelerate. Technicals show constructive momentum and the stock sits well above short-term moving averages. This trade idea outlines an actionable long with entry, stop, and target levels and a clear view of catalysts and risks…
IREN Limited ($IREN) is a high-volatility AI/data-center operator that just cleared several institutional checkpoints (MSCI inclusion, Cantor stake) even as earnings and bitcoin exposure produce headline risk. For active accounts willing to be cash-secured, selling puts around current levels offers asymmetric reward: collect premium today while ins…
LegalZoom (LZ) has been punished with AI angst and recent share weakness, but the underlying business is producing durable subscription revenue, strong free cash flow ($155.8M) and carries virtually no debt. With a market cap near $1.19B and an attractive FCF yield, the risk/reward looks favorable for a long position targeting a reversion toward hi…
Oxford Lane (OXLC) has seen its NAV and share price hammered by unrealized markdowns in CLO equity and junior debt. Management has cut distributions, completed a reverse split and launched a note offering — steps that create a credible, if imperfect, path to stabilize the balance sheet. At current levels the common trades at a roughly 40% discount …
Liberty Global (LBTYA) is a beaten-down major-telecom with a $4.06B market cap and an enterprise value of $10.64B trading at ~EV/EBITDA 9.6. A modest entry here captures upside from strategic portfolio optionality, a five-year Google Cloud deal and improving technical momentum. This trade targets a re-rating catalyst over a 46-180 trading day windo…
CarGurus (CARG) is a $2.9B online automotive marketplace that combines a high-return core marketplace with a growing digital wholesale business and new AI-driven products. At roughly $29.25 today, the stock offers a clear asymmetric trade: reasonable valuation (P/E ~19.8; EV/EBITDA ~10.4), strong free cash flow ($272M last period), and meaningful u…
Lyft is trading like a busted growth story, but the numbers tell a different tale: low valuation multiples, $1.1B in free cash flow, a modest balance sheet and a fresh buyback. Short-term AV uncertainty creates headline risk, but that same fear has widened the risk-reward for disciplined long trades. This plan targets cyclical recovery and executio…
Canon has been a slow-moving compounder. With industrial manufacturing showing tentative strength and packaging-related imaging demand expanding, Canon's mix is starting to look more favorable for a 2026 recovery trade. I am upgrading my rating and proposing a defined-entry long with clear stops and targets over a 180-trading-day horizon.
Remitly shares trade at roughly $17 and a low forward earnings multiple relative to growth targets; Q4 results and guidance clarity create a tactical buy opportunity. This note lays out an entry at $17.03, a stop at $14.75 and a mid-term target of $23.00 with a clear risk framework tied to volume, product adoption and credit trends.
Uber’s core platform — Mobility, Delivery, Freight — is showing profitable scale, positive free cash flow, and structural advantages that the market is underpricing. At roughly $158.3B market cap, the stock trades at mid-teens P/E with a healthy cash flow profile. This trade idea lays out a disciplined long entry at $74.00, a $100.00 target over 18…
Nano Labs (NA) has pivoted hard into crypto reserves and BNB-related infrastructure while slashing operating costs and stabilizing losses. At a market cap of roughly $76M and a current price near $3.21, the stock offers an asymmetric return profile for disciplined traders who accept high volatility, low liquidity and regulatory uncertainty. This tr…
Meta is investing aggressively in infrastructure and data-quality guardrails that make its advertising and AI personalization increasingly defensible. With a market cap around $1.66T, healthy free cash flow and improving AI partnerships, the risk/reward favors a long position over the next 180 trading days, provided you respect valuation and set a …
American Tower looks poised to re-rate as its CoreSite data center business captures AI-driven colocation demand and the stock shows improving technicals. The company offers a 3.6% yield and FCF of roughly $3.7B, supporting a tactical long trade sized for a long-term (180 trading days) horizon. Entry $185.025, stop $170.00, target $215.00.
Arcutis has doubled in a year on accelerating ZORYVE sales and encouraging guidance. Revenue upside is in the numbers — 2026 net product sales guidance of $455-470M implies rapid compounding, but valuation (EV/sales ~11x) already prices a lot of the story. This trade targets further multiple expansion into secular adoption while protecting capital …
Amazon (AMZN) looks great in headlines: top of the Fortune 500 and AWS still dominant. But under the hood the stock is priced for near-perfection, free cash flow recently turned negative, and technical momentum is failing. This actionable short trade targets a retreat toward the $170 area over the next 45 trading days with a $220 stop.
Viatris (VTRS) looks attractively priced today with a market cap near $18.7B, roughly $1.65B in annual free cash flow, and valuation multiples that sit below what you'd expect for a global pharmaceuticals player. Combine that with favorable policy headlines for generics and multiple end-market growth tailwinds, and there is a defendable long trade …
Main Street Capital (MAIN) is trading at about 1.77x book with a ~5.25% trailing dividend yield and a sub-10x P/E. Recent price weakness has pushed technicals into oversold territory and created a tactical long entry for investors who want monthly income plus modest capital appreciation. This trade plan defines a clear entry, stop and target while …
Charles Schwab looks like a buy here around $93.87. The franchise is producing strong revenue and FCF growth, client assets are at record levels, and the stock trades below its short-term moving averages with RSI near 37. Our trade plan: enter at $93.87, stop $86.00, target $110.00 over a 180-trading-day horizon.
Corcept (CORT) plunged after a 12/31/2025 FDA Complete Response Letter for relacorilant tied to hypercortisolism. That sell-off priced in a lot of regulatory and litigation downside; meanwhile relacorilant's oncology potential, especially in platinum-resistant ovarian cancer, remains underappreciated. This trade idea lays out a tactical long with c…
